Cyclerion receives FDA feedback on depression treatment study
Go back to Cyclerion receives FDA feedback on depression treatment study| (NASDAQ: CYCN) | Delayed: 3.18 --3.18 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.00 | 52 Week High | $ | |||
| Open | $3.11 | 52 Week Low | $ | |||
| Day High | $3.18 | P/E | N/A | |||
| Day Low | $3.11 | EPS | $ | |||
| Volume | 746 | |||||
